Pill Identifier App

PAD 214 (Naratriptan 1 mg)

Pill imprint PAD 214 has been identified as Naratriptan hydrochloride 1 mg.

Naratriptan is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Naratriptan 1 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for PAD 214

Naratriptan hydrochloride
Imprint:
PAD
214
Strength:
1 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Antimigraine agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Paddock Laboratories, Inc.
National Drug Code (NDC):
00574-0214
Inactive Ingredients:
croscarmellose sodium
lactose anhydrous
magnesium stearate
microcrystalline cellulose
hypromellose
titanium dioxide
triacetin

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)